chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BODY ACHES; VERY LITTLE ENERGY; HEADACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, very little energy, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the very little energy, body aches and headache was not reported. This report was non-serious.
Patient was administed expired Covid-19 Moderna Vaccine. Notified Moderna when we were made on 11/17/21 by registry and by Public Health. Patient has been called and informed of incident and advised to come in and be given an additional full dose of Covid-19 Moderna Vaccine per the instructions of both Moderna and Public Health.
HEADACHE; FATIGUE; NAUSEA; CLAMMY; MUSCLE ACHE; REDNESS AT INJECTION SITE; RASH AT INJECTION SITE; FEVER; This spontaneous report received from a patient concerned a 24 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no health issues, no allergies. patient never had adverse reaction to vaccine prior. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: 25/MAY/2021) dose was not reported, administered on 20-MAR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported.  On 20-MAR-2021, the subject experienced fatigue. On 20-MAR-2021, the subject experienced nausea. On 20-MAR-2021, the subject experienced clammy. On 20-MAR-2021, the subject experienced muscle ache. On 20-MAR-2021, the subject experienced redness at injection site. On 20-MAR-2021, the subject experienced rash at injection site. On 20-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 100.3. On 21-MAR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 98.6. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 21-MAR-2021, was recovering from fatigue, nausea, and muscle ache, had not recovered from clammy, and headache, and the outcome of redness at injection site and rash at injection site was not reported. This report was non-serious.
At 3:30pm on 1-29-2021 I began to have a severe headache and nausea. At 4:20pm on 1-29-2021 one day after receiving Covid 19 first vaccine, I began violently vomiting  4 times hourly until 8pm on 1-29-2021. I also had 3 loose stools during that time. From 1-30-2021 to 2-1-2021 I have had a headache and nausea in the morning.
Since 4/12/00 muscle pains, joint pains, weakness, fever, lip pains. Disability now being evaluated for oculopharyngeal muscular dystrophy and mitrochondrial myopathy.  60 Day follow up states still has mypathy, general redness. **Follow-up report on 2/19/03: Per phone call from PT's husband on 2/13/03, add lethargy and depression as updates.
Patient felt faint about 5 min's after receiving vaccine for HPV. Pt fell back into mother's arms and was pale. No loss of consciousness. Patient laid down and recovered, then went home.
Patient was exposed to her boyfriend last on 12/19/21. Symptomatic with multiple symptoms since 12/22/21. Positive Covid test on 123/23/21. Isolated  x 10 days until 1/2/21. Patient to callback with f/u. Company aware.
Additional information was received that provided patient information, vaccine administration information, dose site and route of administration and recovery status. Information regarding Prevnar vaccine was received from a dermatologist, who is a parent of the patient, regarding a female child who received the third dose on an unspecified date in 2006 and subsequently developed injection site urticarial eruption and generalized urticarial eruption. On an unspecified date in 2006, the patient received the third dose of Prevnar. Less than 24 hours later, the child developed injection site urticarial eruption that was followed by a generalized urticarial eruption. On an unspecified date, the patient recovered from the events. No additional information was available at the time of this report.
Dose #1 EN 6199 3/10/2021 Dose #2 ER 8132 3/31/2021 Acute PE/DVT on 4/6/2021  Hospitalized with leg swelling shortness of breath Diagnosed with submassive PE, right lower extremity extensive DVT Anticoagulation started subsequently discharged home
Patient received moderna vaccine on 2/5/21 and 3/2/21. Presented to ER on 6/26/22. COVID positive on 6/19/22.   Patient admitted after a positive COVID test outpatient, increasing shortness  of breath and weakness.  Was started on remdesivir and Decadron.  High-flow  oxygen, improved.  Also had CHF which was treated.  Patient's hospital course was prolonged due to age, multiple medical problems.   Now, he is back to baseline. On the day of discharge, patient has no chest pain.  No shortness of breath.   No cough.  No hemoptysis.  No nausea, vomiting, diarrhea. Discharged on 7/7/22
A physician reported the occurrence of uncontrollable crying in a 4 month old female who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The subject's medical history included eczema. Concurrent conditions were not reported. The subject received no concurrent medications. The subject had no adverse experiences following previous immunizations. On 5/5/03, the subject received her second injection of Infanrix (lot DTPA583A2). On 5/7/03, 56 hours post immunization, the subject cried uncontrollably for 5.5 hours. On 5/8/03, the subject was seen by the physician. At that time, the crying had resolved and the subject seemed fine.
1st dose / before Covid19 situation / did not receive 2nd shot yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose of Shingrix received before Covid19 situation, about 1 year ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable to this report. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The VAREs details pertains to 1st Shingrix dose. No further information was reported. The reporter consented to follow up.
This case was reported by a other health professional via call center representative and described the occurrence of cerebral ataxia in a male patient who received Influenza vaccine Quadrivalent. On an unknown date, the patient received Influenza vaccine Quadrivalent. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent, the patient experienced cerebral ataxia. On an unknown date, the outcome of the cerebral ataxia was unknown. It was unknown if the reporter considered the cerebral ataxia to be related to Influenza vaccine Quadrivalent. Additional details were provided as follows: The healthcare professional reported that, the patient experienced cerebral ataxia after receiving an unknown brand flu vaccine. The HCP declined to provided patient's date of birth. No additional information would be obtained.
All over arthritis, edema in ankles and feet. Bright red splotches and rash, fever hardly could stand up. About 2 weeks duration. No treatment except V/CODIN for pain in feet.
Patient said he experience numbness on the left side of his body for 20 minutes after the  administration of the flu vaccine. Patient claimed he recovered after 20 minutes.
Swelling of lymph nodes under armpit on side vaccine was administered and possible swelling of lymph nodes in neck. Pt. went to ER but did not need to.
Patient's mother filled out patient's date of birth as (12 yo)  but in fact the correct date of birth is (11 yo). Patient's mother later admitted she provided incorrect date of birth so her daughter is eligible for the vaccine.
Two days after being vaccinated 3/18/21  that night I was complaining of my back itching and some pain in my back.  I had my girlfriend look at my back she stated i had some red large pimples on my back.  The next morning I had hives on my chest between my right and left breast,  hives on my left side lats and my back area.  The hives itched burned, and were a bit painful.  I used alovera and witch hazel wipes and hydrocortisone.  As of today 3/22/21  I'm feeling a little better and i have an appointment with my primary care 3/23/21.
My heart rate would not come down below 100.  I left the clinic after 15 mins because I thought it was going to come down.  On my way home, my tongue and throat felt funny so I took one Benadryl when I got home.  My tongue and mouth felt better but my heart rate never came down.  I tried lying down on the bed and meditating but it still would not get below 100.  It felt like my heart was beating out of my chest.  I took an epi pen around 2pm and called my doctor's office   The PA instructed me to go to the hospital which I did.  The epi pen made my heart rate shoot up to 150.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; RIGHT EYE LID SWOLLEN; RIGHT EYELID REDNESS; This spontaneous report received from a parent concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid-19. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) 1 total, administered on JUL-2021 (end of JUL-2021) for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date in AUG-2021, two weeks after the patient received vaccine, the patient experienced swollen right eye lid and had redness. It happened daily and had varying degrees of redness and swollen. It (redness and swollen) presented again two days before he took a rapid test and got COVID again. He never had right eye lid issue before receiving vaccine. Its intensity was on and off. On 02-JAN-2022, the patient was diagnosed with COVID (suspected clinical vaccination failure and suspected covid-19 infection). Laboratory data included: COVID-19 rapid POC test (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the right eye lid swollen, suspected covid-19 infection, suspected clinical vaccination failure and right eyelid redness was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000211631.; Sender's Comments: V0:20220121837 covid-19 vaccine ad26.cov2.s - Suspected clinical vaccination failure This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically:SPECIAL SITUATIONS
Patient received 0.25 mL of Bivalent dose instead of 0.5 mL/wrong dose for Bivalent Vaccine booster dose (underdose)/Patient was administered an invalid dose of Moderna COVID-19 bivalent booster; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received 0.25 mL of Bivalent dose instead of 0.5 mL/wrong dose for Bivalent Vaccine booster dose (underdose)/Patient was administered an invalid dose of Moderna COVID-19 bivalent booster) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Patient received 0.25 mL of Bivalent dose instead of 0.5 mL/wrong dose for Bivalent Vaccine booster dose (underdose)/Patient was administered an invalid dose of Moderna COVID-19 bivalent booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received 0.25 mL of Bivalent dose instead of 0.5 mL/wrong dose for Bivalent Vaccine booster dose (underdose)/Patient was administered an invalid dose of Moderna COVID-19 bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient received 0.25 mL of Bivalent dose instead of 0.5 mL/wrong dose for Bivalent Vaccine booster dose (underdose)/Patient was administered an invalid dose of Moderna COVID-19 bivalent booster).    No concomitant medications were reported.  It was reported that, the nurses had no standing orders other than what they had for the second booster, when first administering Bivalent boosters. So, they assumed the same dose as the second booster, that was they were administering 0.25 mL instead of 0.5 mL to uncompromised adults.  No adverse events were reported.  No treatment medications were reported.
Narrative: COVID infection following COVID vaccine series 01/08, Pfizer, dose #1 01/28, Pfizer #2 10/18, Pfizer, dose #3 08/10 pt cc: SOB, fever, chills, CP exposure; deceased wife 09/01 COVID swab, result: detected 09/02 clinically resolved
extreme fatigue; rash on his arm; Itching; This is a spontaneous report received from a contactable consumer, the patient. This case is reported for first dose. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date in 2021 (as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient received the first dose a couple of weeks ago and he was experiencing extreme fatigue and rash on his arm. The rash comes and goes. Adds at one point he thought he was having liver or kidney problems but it all checked out. He has been itching over a week. The patient knew he would experience some kind of reaction. Outcome of the event was unknown. Information about batch/Lot number has been requested.
Robust local reaction, 3 inches of erythema and induration.  Low grade temp 100.6.  Fatigue.
Patient calls the local health dept. to report an adverse reaction after receiving the Moderna vaccine. Vaccines were administered by Pharmacy at the patient's place of employment at Nursing Home. Patient reports he developed Bell's Palsy in June 2021 and it continues today.
STROKE/HEADACHE; BLOOD CLOT; INJECTION SITE REACTION; PAIN IN ARM; This spontaneous report received from a patient concerned a 79 year old male.  The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered to left arm on 11-MAR-2021 for prophylactic vaccination.  No concomitant medications were reported.  On 25-MAR-2021, 2 weeks after receiving the vaccination, the patient stated his injection site on his left arm "felt horrible" "like someone was stabbing him in that joint" (both events captured as injection site reaction). The patient reported his doctors did not know what was causing this and he could not get rid of it. On an unspecified date the patient experienced headaches with one being described as going from the back of his head to his left temple, he reported not usually having headaches. The patient also experienced severe pain when moving left arm with pain worsening at night when not moving. The patient was unable to reach up to grab things.  On 24-APR-2021, the patient was taken to the hospital and was diagnosed as had a stroke. On an unspecified date results of Magnetic Resonance Imaging (MRI) were 'blood clots in the artery that goes up middle of spine and back of neck. The patient stated the results also had "right side numbness, vertigo, slurred speech". Results of Computerised Tomogram (CT) (date unspecified) were per the patient "internal carotid arteries demonstrated calcified plaque, stenosis, arteries demonstrate localized  three-four segment of left local artery". The patient was discharged on an unspecified date and had not seen his regular physician yet. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the stroke, blood clot, injection site reaction, pain in arm and headache was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0 -covid-19 vaccine ad26.cov2.s-Stroke/Blood clot. This case concerns a patient of 79 year old male. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history concurrent conditions, drug reactions and allergies were not reported. The patient's concomitant medications included sterile diluent (MERCK STERILE DILUENT) Lot # N013297 and expiration date 25-SEP-2019. On 02-MAY-2018, the patient was vaccinated with an expired dose of VARIVAX for prophylaxis, lot #M005972 and expiration date  02-FEB-2018 (strength, dose, frequency and route of administratin were not reported). No adverse event was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1805USA001997: US-009507513-1805USA002675:
The vial expired on 02May2022, was pulled from freezer at 10AM on 03May2022 and was put in refrigerator until approximately 1:45 PM; 12 doses administered past manufactures expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (12 doses administered past manufactures expiration date) and PRODUCT STORAGE ERROR (The vial expired on 02May2022, was pulled from freezer at 10AM on 03May2022 and was put in refrigerator until approximately 1:45 PM) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045J21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine. Past adverse reactions to the above products included No adverse event with Pfizer vaccine.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 03-May-2022 at 2:10 PM, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (12 doses administered past manufactures expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial expired on 02May2022, was pulled from freezer at 10AM on 03May2022 and was put in refrigerator until approximately 1:45 PM). At the time of the report, EXPIRED PRODUCT ADMINISTERED (12 doses administered past manufactures expiration date) and PRODUCT STORAGE ERROR (The vial expired on 02May2022, was pulled from freezer at 10AM on 03May2022 and was put in refrigerator until approximately 1:45 PM) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (12 doses administered past manufactures expiration date) to be related. No further causality assessment was provided for PRODUCT STORAGE ERROR (The vial expired on 02May2022, was pulled from freezer at 10AM on 03May2022 and was put in refrigerator until approximately 1:45 PM).    No concomitant medications were reported by the reporter.  All 12 doses were administered between 2-3 PM on 03-May-2022  The vial was initially stored in the refrigerator was pulled from freezer at 10AM on 03-May-2022 and was put in refrigerator until approximately 1:45 PM.  No the vial did not undergo any temperature excursions.  No treatment medications were reported by the reporter.
Acute diastolic heart failure. ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Pain at injection site.  What started as a small pimple sized bump has grown into a egg sized bump. Painful to touch
Patient received 1st dose of Moderna on 09/28/2021. He was due 10/26/2021 for second vaccine. Patient was given Second dose of Moderna on 09/19/2021. It was given 21 days after first dose Moderna vaccine instead of the recommended 24 day after first vaccine.
Moderna COVID-19 Vaccine EUA  Received the injection in the shoulder near the shoulder blade. (Is that a normal injection site??) Arm felt fine the day of the vaccine. The next two days my arm, especially the shoulder joint was sore whenever I moved my arm. I took tylenol which worked for awhile. After the two days, my arm felt fine. Full range of movement again without pain without medication.
CDC,  made me extremely Ill once again with you Experimental ( & yes; they ARE experimental), TOXIC vaccines.  Mandatory for work. No more EVER, not EVER, no  more of your toxic experiments will be performed on me. Do you have any idea how scary it is to be unable to bend any joints including fingers? I could barely even walk, it was that bad.  Do you care? Obviously NO! Dry cough started that evening, next day muscular & joint pain,  evening 101 fever, deep ache in armpits, nasty headache, diarrhea, watery bloodshot eyes, that turn goopy 3rd time!?all from your stinking vaccine booster. To keep ppl safe my eye. Failed to keep me safe. I was in no way getting sick, or was I sick before. Tired of this nonsense society buys into & that you sell ppl.  Every single time your vaccines have been given, they make me very sick.
Redness and swelling in arm with decreased movement. Given Benadryl and placed on antibiotics per ER physician.
This spontaneous report was received from a nurse, concerning a 56 years old female patient. There were no concurrent conditions, medical history, drug reactions or allergies or concomitant medications reported. On 06-FEB-2017, the patient was vaccinated with a pediatric dose of VAQTA for prophylaxis (dose, frequency, route, lot # and expiration date were not reported) instead of the adult dose. No adverse effects were reported. No product quality complaint was involved (PQC).  Additional information has been requested.